Sama Alreddawi

Sama Alreddawi practices at Luminis Health Anne Arundel Medical Center in Annapolis, Maryland, part of Luminis Health.

Sama Alreddawi's NPI, 1497288112, was assigned on April 10, 2017. Sama Alreddawi holds Maryland license D0089476.

Sama Alreddawi's primary practice is Luminis Health Anne Arundel Medical Center, at 2001 Medical Parkway, Annapolis, MD 21401 in Anne Arundel County. The practice phone is (443) 481-1000.

Sama Alreddawi's primary practice is Luminis Health Anne Arundel Medical Center in Annapolis, Maryland, part of Luminis Health. The medical group on file is Luminis Health Maternal and Fetal Medicine Annapolis.

Dmand AI tracks the electronic health record (EHR) system at each site where Sama Alreddawi practices. Vendor and product names are available with a free account.

Internal medicine is Sama Alreddawi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Sama Alreddawi is licensed in Maryland.

CMS data shows 457 Medicare services from Sama Alreddawi across 12 procedure codes in 2024, for 308 Medicare patients. Medicare paid $34,791 for them.

CMS counts 308 Medicare patients who saw Sama Alreddawi in 2024. The largest group is 65 to 74, with 144 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sama Alreddawi's median patient age at 56, with 51% women.

In 2024, Sama Alreddawi wrote 14 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $328 in total drug cost. In 2019, CMS named 75 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Sama Alreddawi for performance year 2024, reported as part of a group. Sama Alreddawi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Sama Alreddawi in 2019. Sama Alreddawi's most frequent co-authors are Roberto Salvatori, MD and Leen Wehbeh, MD.

CMS Open Payments shows 2 general payments to Sama Alreddawi from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $29.